Jan 04, 2021
Biocept to Present at H.C. Wainwright Virtual BioConnect Conference
Dec 31, 2020
Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dec 30, 2020
Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations
Dec 14, 2020
Biocept Provides Business Update
Dec 10, 2020
Biocept's Target Selector(TM) Liquid Biopsy Demonstrated High Accuracy When Used for Monitoring the Progression of Metastatic Breast Cancer in Study Conducted at Johns Hopkins Sidney Kimmel Cancer Center
Nov 20, 2020
Study Shows Biocept's Assays are Viable and Sensitive for Detecting Tumor Cells and Biomarkers in the Cerebrospinal Fluid of Patients with Breast and Lung Cancer that has Metastasized to the Central Nervous System
Nov 17, 2020
Results from Study Using Biocept's Target Selector(TM) Testing to Monitor Breast Cancer Disease Progression to be Presented at 2020 SABCS®
Nov 12, 2020
Biocept Reports Third Quarter 2020 Financial Results
Nov 12, 2020
Biocept Provides Update on COVID-19 Testing with More than 100,000 Samples Received
Nov 04, 2020
Biocept to Release Third Quarter 2020 Financial Results and Host Investor Conference Call on November 12, 2020
Oct 06, 2020
Biocept Provides Update on COVID-19 Testing with More than 50,000 Specimens Received
Oct 05, 2020
Study Shows Biocept's Target Selector(TM) May Provide a More Robust Method for Detecting Lung Cancer Metastasis in Cerebrospinal Fluid than Cytology
Oct 01, 2020
Biocept to Present Study Results from Target Selector(TM) Testing in the Cerebrospinal Fluid of Patients with Lung Cancer at the IASLC Liquid Biopsy Meeting
Sep 23, 2020
Biocept Announces the Award of Japanese Patent for Primer-Switch Mutation Detection and Amplification Improvement Platform Used to Detect Rare Cell Mutations in Tissue, Blood and Cerebrospinal Fluid
Sep 21, 2020
Biocept Announces that Highmark Has Made a Positive Coverage Determination on Target Selector(TM) Liquid Biopsy
Sep 09, 2020
Biocept to Present at the H.C. Wainwright Global Investment Virtual Conference on September 14
Sep 08, 2020
Biocept Executes In-Network Provider Agreement with Health Net Federal Services Extending Coverage for its Liquid Biopsy Oncology Platform to the TRICARE West Region Network
Aug 31, 2020
Biocept Provides COVID-19 Testing Update with More Than 21,000 COVID-19 Specimens Received and More than 20,000 Specimens Processed
Aug 27, 2020
Biocept to Present at the LD Micro 500 Virtual Conference
Aug 13, 2020
Biocept Announces Agreement with Healthcare Group to Provide COVID-19 Testing to Multi-State Locations